GALT Galectin Therapeutics Inc

$GALT 1. Early 2026 Summit Therapeutics requested increase in shares. Then announced a partnership in Sept with AstraZeneca for $2 bil (12% stake). They were in Phase 3 2. Early 2024, Novavax requested an increase in shares. In May 2024, before the meeting, company announced a $1.2 bil licensing agreement w/ Sanofi (4.9% stake). They were in Phase 2 3. In 2022, Horizon Therapeutics announced a meeting requesting an increase in shares. In Dec 2022 company acquired by Amgen for $27.8 bil. FDA approved drugs and multiple in Phase 1/Phase 2 4. Brickell Biotech scheduled meeting to vote on RS and increase in shares from 300 to 525 million in May 2022 . Before the meeting, a definitive purchase agreement by Botanix Pharmaceuticals. They were in Phase 3 5. Late 2022 CinCor Pharma sought out either issuance of new shares or execution of a dilutive secondary offering to fund ongoing trials. In January 2023, the company was acquired by AstraZeneca for $1.8 bil. They were in Phase 2 Is there more?

$GALT Barring any unforeseen developments, looks like we have a P3 ready asset heading into next week's AASLD meetings. Nice job management.

$GALT dubstep- you are accomplishing nothing with your rants. The AASLD starts in two weeks, and management has submitted the P3 protocol to the FDA. That's all I know, and like everyone else who has INVESTED here, I am waiting for further details. Good luck to you.

$GALT This might be the last good buying opportunity before DU shows his cards. I’m guessing he has the straight flush.

$GALT I'm convinced there will be a buyout. Looking for golden parachutes, I see with this Omnibus increase proposal the execs will increase the last RSU from 4M to 7M, that's their parachute, no doubt to clear immediately on acquisition. The timing of this all is not coincidence, FDA alignment in June, submittal of abstracts to the liver conference on Nov 5, submittal of P3 protocol with 30 day turnaround time aligns perfectly.

$GALT Upcoming liver meetings should be very good to us. My sense is that we are receiving greater acceptance of our drug by liver KOLs and industry leaders. Also appears to be doubts developing as to how well RESM works (see recent, including today, MDGL stock plunge). Just my opinions, not investment advice.

$GALT These guys are doing one last attempt to shake the tree and see if weak hands fall out. I see this coordinated with blatantly false posts. Don’t let them get away with it. I’ve been adding this week.

$GALT Galt has a partner, they vote on a 3 million share distribution package to the remaining employees of GALT in December, this is the last thing you do before you sell or partner up give a ton of shares to you and your co-workers Once 3rd trial is approved they will announce, remember they don’t have enough money on hand to fund a 3rd trial.

$GALT Added some more. Ridiculous low price is an advantage for those who are able to load up before the phase 3 registration trial package launches.

$GALT when I get stupid rich some day. I’m going to retire and start making AI movies. I’m already working on my first one.

$GALT Joel gets LOADS of credit here. This is what we call a well-run company. Not based on hype and fluff. Methodical and calculated. In the social media era many people fall for who can shout louder. We are fortunate to have a CEO who does not pay attention to the hysteria and does his job the right way. Thats why we are in this position. Thank you JL for getting us here

$GALT $XBI The short sell manipulator getting his ass back in jail soon. The filing asks the judge to order Shkreli's sister, Leonora Izerne, and his "significant other, Chelsea Voss," to preserve all evidence relating to potential violations of the injunction against Shkreli because both women "appear to have assisted or be assisting Shkreli in violating the Permanent Injunction." https://www.cnbc.com/amp/2026/10/13/martin-shkreli-ftc-pharma-contempt.html

$GALT That phase 3 should be a confirmational outcomes trial with AA approved when the trial begins. Similar to what Madrigal did but using a hard clinical endpoint to fulfill subpart H and not a BS surrogate biopsy.

$GALT less than a week from now we should know if the phase 3 protocol is approved by the fda. And what do shorts do then? Because once this is a phase 3 approved drug it significantly increases the value of the company. To a partner. To a buyer. That should be Joel’s work done. They will have achieved maximum valuation. And regulatory clarity. Without further investment. They aren’t going to fund or run a phase 3 themselves. It will be partner/ buyer time. Because the suitors boards and lawyers will have exactly what they need to sign a deal because they’ll know how much they’ll need to run the trial and what the market is once it’s approved. ( a market that just increased significantly with the new primary endpoint of avoiding large varices) So shorts can sell it down on a Friday but no matter how low it goes they can’t cover 9 million shares in a week to avoid a massive wealth destroying squeeze. Let’s count it down. 5 more trading days. 5. 4. 3. 2. 1.

$GALT https://www.cnbc.com/2026/10/13/martin-shkreli-ftc-pharma-contempt.html The government should investigate who was paying Martin to bring attention to certain biotech companies and why. Doesn’t take a rocket scientist to see Martin was a hired gun. For who is the question?

$GALT Assuming on September 30th, the Company has submitted a registrational protocol for the Phase 3 trial of belapectin for the prevention of disease progression in patients with MASH cirrhosis and portal hypertension to the U.S. Food and Drug Administration (FDA). If everything is cleared, they may start Ph3 in November, 2026. Most of the time, the company has to hired more employees to prepare for ph3 study. But at this time, still have no openings and don’t have enough money to start ph3 by themselves? FDA green light 🚥 then announce partnership or BO? Pick your choice.

$GALT Weeks ago I realized that the frequent posts by 2 or 3 accounts here really don't add much to this board, and that reading those posts was costing me a whole lot of time. So I blocked or muted them. Believe me when I tell you it is positively life-changing! Ja, it's wunderbar! Highly recommended!

$GALT LLY Lilly casually adding another 40+ billion to its market cap in premarket. mainly due to 1product… time to enlarge your portfolio by spending some $? 40B is good and pocket money for you 😅

$GALT When in doubt ask yourself… why did DU convert his debt to shares after all this time only to then shortly thereafter raise more shares and in effect dilute himself? Hmmm, probably because he’s a bored billionaire with uncanny timing, of course; or he has a very strategic plan laid out. People like DU leave a crumb trail, and aren’t going to be too direct about strategies, partners, etc. He appointed Joel for a reason. His letter long ago asked us to invest alongside him, which was genuine in my opinion. Company is in its best position, ever. Be patient and devour these low prices that will multiply in unexpected fashion. 🍻

$GALT not a large add, but I am adding another $2000 here this week. That will take me over 16k shares in size and I will be pushing to hit 20k shares before end of November unless we get a substantial event before then.